Article
Top 5 Most Listened to Podcast Episodes of 2022
Author(s):
The top 5 most listened to podcast episodes on AJMC.com in 2022 provided expert commentary on diabetes, lung disease, health policy, Parkinson disease, and more.
The most listened to episodes of Managed Care Cast explored a possible cure to Parkinson disease, financial toxicity in cancer care, treatment goals for those affected by interstitial lung disease, diabetes prevention, and efforts to curb sexually transmitted infections (STIs) in America.
Here are the top 5 episodes of Managed Care Cast this year.
5. New California Law Addresses STI Epidemic With At-Home Test Kits
To curb the epidemic of STIs in the United States, California enacted law SB-306. Amy Moy, the chief external affairs officer at Essential Access Health, discusses the function of SB-306, its role in perceived stigma with STI testing, and what else can be done to decrease the impact of STIs in California and the United States.
4. Major Study Expands in Hopes to Cure Parkinson Disease
This episode’s guest is Roseanne D. Dobkin, PhD, who is a clinical psychologist and associate professor of psychiatry at the Robert Wood Johnson Medical School at Rutgers University. She is an investigator on the Parkinson’s Progression Markers Initiative study, supported by the Michael J. Fox Foundation for Parkinson’s Research. The international study aims to end Parkinson disease, which is projected to double by 2040 to more than 14 million people diagnosed globally.
4. Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
Meghan Guterrez, CEO of the Lymphoma Research Foundation, discusses financial toxicity, how cancer patients’ financial needs have been impacted by the pandemic, health care disparities and gaps in care, and more. The podcast was recorded just after President Joe Biden announced the return of the Cancer Moonshot program he initiated during his time as vice president in the Obama administration.
3. Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 2
In a pair of podcast episodes, Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute, moderated a discussion on the treatment landscape, up-and-coming therapies, and unmet needs in interstitial lung disease (ILD). This episode covered the second half of the conversation.
2. Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1
In the first part of this podcast discussion, the panel of experts explored the treatment goals of patients with ILD with a review of standard of care therapies and treatment paradigms.
1. How Can Employers Leverage the DPP to Improve Diabetes Rates?
In our most listened to podcast of the year, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains how the coalition aims to reduce the rate of diabetes through the Diabetes Prevention Program (DPP). Hutt also discusses COVID-19’s influence on preventing diabetes and how employers who want to get involved in the initiative can join.
How Can Employers Leverage the DPP to Improve Diabetes Rates?
